Japer Therapeutics, Inc. Warrants (JSPRW) Total Assets by Year
Japer Therapeutics, Inc. Warrants closed fiscal year 2025 with $35.8M in total assets, $31.6M in total liabilities and $4.2M in shareholder equity. Total assets fell 55.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Japer Therapeutics, Inc. Warrants has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
JSPRW Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $35.8M-55.2% | $79.9M-15.8% | $94.9M+96.2% | $48.4M-48.4% | $93.7M+301.0% | $23.4M |
| Total Liabilities | $31.6M+73.5% | $18.2M+10.8% | $16.5M+33.0% | $12.4M-48.7% | $24.1M-58.7% | $58.5M |
| Total Equity | $4.2M-93.3% | $61.7M-21.4% | $78.4M+118.0% | $36.0M-48.2% | $69.5Mn/m | -$35.1M |
JSPRW Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.8M-74.6% | $21.2M-63.2% | $35.8M-55.2% | $57.5M-42.2% | $46.5M-59.2% | $57.6M-54.3% | $79.9M-15.8% | $99.4M-10.0% | $113.9M-8.2% | $126.0M-9.2% | $94.9M+96.2% | $110.4M+86.8% |
| Total Liabilities | $10.4M-54.8% | $17.8M+15.8% | $31.6M+73.5% | $45.9M+191.7% | $23.0M+68.6% | $15.4M+20.6% | $18.2M+10.8% | $15.7M-3.3% | $13.6M-2.5% | $12.7M-6.1% | $16.5M+33.0% | $16.3M+40.9% |
| Total Equity | $1.4M-94.0% | $3.4M-92.0% | $4.2M-93.3% | $11.6M-86.2% | $23.5M-76.6% | $42.2M-62.7% | $61.7M-21.4% | $83.7M-11.1% | $100.3M-9.0% | $113.2M-9.6% | $78.4M+118.0% | $94.1M+97.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Japer Therapeutics, Inc. Warrants financials
Frequently Asked Questions
What was Japer Therapeutics, Inc. Warrants's total assets in fiscal year 2025?
Japer Therapeutics, Inc. Warrants closed fiscal year 2025 with $35.8M in total assets, $31.6M in total liabilities and $4.2M in shareholder equity.
How fast is Japer Therapeutics, Inc. Warrants's total assets growing?
Japer Therapeutics, Inc. Warrants (JSPRW) total assets fell by 55.2% year over year, from $79.9M to $35.8M in fiscal year 2025.
How has Japer Therapeutics, Inc. Warrants's total assets changed over the years?
Across the 6 fiscal years this page covers, Japer Therapeutics, Inc. Warrants (JSPRW) total assets went from $23.4M in fiscal year 2020 to $35.8M in fiscal year 2025.
What was Japer Therapeutics, Inc. Warrants's total assets in the most recent quarter?
Japer Therapeutics, Inc. Warrants (JSPRW) reported $11.8M in total assets in Q2 2026. This represents a decrease of 74.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Japer Therapeutics, Inc. Warrants (JSPRW) reported on that line in every period on record.